No photo available
Details - Information last confirmed on June 8, 2021
The company manufactures and sells nutritional supplements (i.e. multivitamins and probiotics) for individuals who have difficulty absorbing fats and fat-soluble vitamins as seen in cystic fibrosis (CF) and non-CF exocrine pancreatic insufficiency (Non-CF EPI). The company serves the needs of the CF community, including patients and their families; and physicians and care team members, across a network of more than 130 accredited adult and pediatric CF care centers through its products, services and support.
· Recognized as #1 worldwide provider in specialty multivitamins in market
· North American market leader within just in 5+ years
· Multiple brands to support prescriber preference and clinical need
· Complimentary disease-based products within nutritional franchise
· Custom formulations based on customer/country need
· Financials as of 05/31/2020
•Acquisition of a complimentary product portfolio
•Partner with an existing nationally-based sales team
•Growth of secondary brands
•Further expand markets outside the United States (U.S.) and Canada
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.